US Patent 11685731 Processes of preparing a JAK1 inhibitor

Patent

Incyte

Incyte

US Patent 8486902 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile

US Patent 8691807 Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors

US Patent 8716303 N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

US Patent 8987443 Processes and intermediates for making a JAK inhibitor

US Patent 9181271 Tricyclic fused thiophene derivatives as JAK inhibitors

US Patent 9193733 Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors

US Patent 9249145 Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

US Patent 9359358 Cyclohexyl azetidine derivatives as JAK inhibitors

US Patent 9382231 Bipyrazole derivatives as JAK inhibitors

US Patent 9498467 Treatment of chronic neutrophilic leukemia (CNL) and atypical chronic myeloid leukemia (aCML) by inhibitors of JAK1

United States Patent and Trademark Office

Joseph R Kosack